Skip to content

Characterization of an Optically Pumped Magnetometer (OPM) Magnetoencephalography (MEG) Array

Characterization of an Optically Pumped Magnetometer (OPM) Magnetoencephalography (MEG) Array

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04950309
Enrollment
100
Registered
2021-07-06
Start date
2022-05-12
Completion date
2032-08-01
Last updated
2026-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal Physiology

Keywords

Imaging, biomagnetism, somatotopy, optically pumped magnetometer, Magnetoencephalography

Brief summary

Background: Brain activity produces magnetic fields. These fields can be measured outside the head. Existing technology, called MEG, measures these fields. Researchers are testing a new type of magnetic field sensor called OPM. They hope it can help pinpoint with very high accuracy where brain activity is generated. Objective: To develop and test a new type of sensor for measuring the magnetic fields produced by brain activity. Eligibility: Healthy people ages 18-70 who had a magnetic resonance imaging (MRI) scan under protocol 17-M-0181. Design: Participants may be asked to complete sessions on both the traditional MEG instrument and the OPM array. For the MEG, 3-6 small coils will be placed on the participant s face with tape. Their head will be positioned inside the MEG device. For the OPM, sensors are housed in a 3d printed array. The sensors will be attached to a cap placed on the participant s head. For both scans, participants will be seated in a chair inside a magnetically shielded room. They may complete several tasks. In one task, plastic cells will be placed on their fingers. Puffs of air will be sent to these cells, which will stimulate the sense of touch. Other tasks may include the following stimuli: visual (such as checkerboards), auditory (such as beeps and tones), or language (words and letters). Researchers may also obtain recordings while they stimulate the nerve in the participant s forearm using electrical current in small electrodes. Participation is expected to last for 1 day. Additional optional scans may be offered for up to 1 year....

Detailed description

Study Description: This protocol is a technical development protocol to characterize an optically pumped magnetometer (OPM) array used for measuring magnetic brain signals. We hypothesize that with our OPM arrays, we can achieve similar or better spatial resolution to that of a conventional MEG system. Objectives: Primary Objective: To fully characterize the performance of an OPM MEG array at all stages of development. Secondary Objective: To demonstrate that the OPM system can produce somatotopic maps, tonotopic maps, retinotopic maps, and/or maps of receptive language fields. Tertiary Objective: To demonstrate the ability of the OPM system to obtain high SNR and high resolution maps of the cardiac cycle. Endpoints: Primary Endpoint: OPM array characterization parameters including signal to noise, sensitivity, bandwidth, and spatial resolution, and comparison to similar parameters acquired on a standard SQUID system. Secondary Endpoint: Somatotopic representations of the digits of the hand, tonotopic mapping of tone frequency, mapping of visual receptive fields, and mapping of the receptive language system.

Interventions

DEVICESQUID MEG

MEG recordings acquired on a standard whole brain SQUID MEG system. Stimuli will be used, including auditory, visual, or somatosensory stimuli. Language stimuli and median nerve stimulation may also be used.

DEVICEOPM MEG

MEG recordings acquired on an investigational OPM MEG system. Stimuli will be used, including auditory, visual, or somatosensory stimuli. Language stimuli and median nerve stimulation may also be used.

Sponsors

National Institute of Mental Health (NIMH)
Lead SponsorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Provision of signed and dated informed consent form 2. Stated willingness to comply with all study procedures and availability for the duration of the study 3. Male or female, aged 18-70 4. In good general health as evaluated according to protocol 17-M-0181 5. Completed a magnetic resonance imaging (MRI) scan under 17-M-0181

Exclusion criteria

An individual who meets any of the following criteria will be excluded from participation in this study: 1. Participants excluded from 17-M-0181 will be excluded from this protocol 2. Metal in the body which would cause artifacts on MEG recordings

Design outcomes

Primary

MeasureTime frameDescription
array characterization metricsthroughout protocolAt each phase of array construction characterization parameters including signal to noise, sensitivity, bandwidth, and spatial resolution will be measured.

Secondary

MeasureTime frameDescription
Somatotopic representationsthroughout protocolSomatotopic representations of the digits of the hand, potentially differentiating the individual phalanx of each finger.

Countries

United States

Contacts

CONTACTAnna M Namyst
anna.namyst@nih.gov(301) 402-2445
CONTACTAllison C Nugent, Ph.D.
nugenta@mail.nih.gov(301) 451-8863
PRINCIPAL_INVESTIGATORAllison C Nugent, Ph.D.

National Institute of Mental Health (NIMH)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 9, 2026